Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Cutaneous Lymphoma and Disorders of Systemic Disease: Updates and Potential Gaps
Description
The presentation focuses on updates regarding cutaneous lymphoma, particularly Mycosis fungoides and its variants, and discusses potential gaps in understanding and diagnosis. The speaker highlights that there are several variants of Mycosis fungoides, including the folliculotropic and interstitial types, which can overlap with other dermatoses, emphasizing the importance of careful diagnosis through clinical and histological evaluations. They note the emergence of unusual immunophenotypes and variants, such as hyperpigmented and urticarial Mycosis fungoides, which can complicate treatment plans. Furthermore, there are discussions surrounding lymphomatoid papulosis and its presentations, including unusual and persistent forms, which require a nuanced understanding to distinguish from aggressive lymphomas. Other topics covered include the overlap between T-cell and B-cell features in certain lymphoproliferative disorders and the advancements in diagnostic techniques like next-generation sequencing. Lastly, the implications of dupilumab in patients with atopic dermatitis and its potential link to the development of CTCL were examined, highlighting a knowledge gap concerning its long-term effects. The speaker encourages continued research and awareness of these gaps to enhance patient care.
View moreConclusions
- Mycosis fungoides can have multiple non-classic subtypes, including hyperpigmented and folliculotropic variants that may complicate diagnosis.
- There is a notable overlap between different forms of cutaneous T cell lymphomas and benign conditions, which can lead to misdiagnosis.
- Gamma delta T cell receptor expression can occur in lymphomatoid papulosis and other similar conditions, challenging the perception of aggressive behavior associated with this immunophenotype.
- Histological and immunophenotypic characteristics of lymphomatoid papulosis show variability, which suggests that existing definitions might not be universally applicable.
- Dupilumab may increase the risk of developing cutaneous T cell lymphoma in patients with atopic dermatitis, necessitating careful monitoring.
- The use of next-generation sequencing for assessing T cell receptor clonality is more sensitive and specific than traditional methods, highlighting gaps in existing diagnostic practices.
- Dupilumab therapy can unmask underlying lymphoma in patients who may already have an indolent disease prior to treatment.
- JAMA Dermatol. 2013;149(7):819-824.
- J Cutan Pathol. 2024;1-9.
- LEUKEMIA & LYMPHOMA 2022, VOL. 63, NO. 7, 1598-1606.
- J Cutan Pathol. 2024;51:649-653.
- Australas J Dermatol. 2024;65:484-487.
- Clin Exp Dermatol. 2023 Mar 22;48(4):383-386.
- Dermatopathology 2025, 12, 6.
- Am J Surg Pathol 2024;48:501-510.
- J Cutan Pathol. 2024;51:468-476.
- J Cutan Pathol. 2024;51:868-875.
- J Am Acad Dermatol 2024;91:255-8.
- JAAD 2024 Apr;90(4):839-841.
- International Journal of Dermatology 2023, 62, 862-876.